Aster DM Healthcare Schedules Q3FY26 Earnings Conference Call for February 02, 2026

1 min read     Updated on 27 Jan 2026, 12:05 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Aster DM Healthcare has scheduled its Q3FY26 earnings conference call for February 02, 2026, at 11:00 AM IST to discuss unaudited financial results for the quarter and nine months ended December 31, 2025. The call will feature senior management including Chairman & Managing Director Dr. Azad Moopen, Deputy Managing Director Ms. Alisha Moopen, and other key executives. The announcement was made in compliance with SEBI Regulation 30 requirements, with registration details provided for analysts and investors.

31041303

*this image is generated using AI for illustrative purposes only.

Aster DM Healthcare has formally announced its earnings conference call scheduled for February 02, 2026, at 11:00 AM IST to discuss the company's unaudited financial results for the quarter and nine months ended December 31, 2025. The announcement was communicated to both BSE Limited and the National Stock Exchange of India Ltd on January 27, 2026, in compliance with regulatory requirements.

Regulatory Compliance and Communication

The earnings call announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Hemish Purushottam signed the official communication, ensuring proper adherence to disclosure norms for listed companies.

Management Participation

The Q3FY26 earnings conference call will feature comprehensive representation from Aster DM Healthcare 's senior management team. The following executives will participate in the call:

Position: Name
Chairman & Managing Director: Dr. Azad Moopen
Deputy Managing Director: Ms. Alisha Moopen
Non-Executive Director: Mr. T J Wilson
Chief Operating Officer: Mr. Ramesh Kumar S
Chief Financial Officer: Mr. Sunil Kumar M R
Chief Investor Relations & M&A Officer: Mr. Hitesh Dhaddha

Call Details and Access Information

The earnings conference call is specifically designed for analysts and investors to gain insights into the company's financial performance for Q3FY26. The call will provide detailed discussions on the unaudited financial results covering both quarterly and nine-month periods ended December 31, 2025.

Event Details: Information
Date: Monday, February 02, 2026
Time: 11:00 AM IST
Purpose: Q3FY26 Financial Results Discussion
Reporting Period: Quarter and nine months ended December 31, 2025

Corporate Information

Aster DM Healthcare operates from multiple locations with its registered office located at No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev Reddy Nagar, Hyderabad, Ameerpet, Telangana, India - 500038. The company's corporate office is situated at Awfis, 2nd Floor, Renaissance Centra, 27 & 27/1, Mission Road, Sampangi Rama Nagar, Bengaluru, Karnataka, India - 560027.

For additional clarification regarding the earnings call, interested parties can reach out via email to investors@asterdmhealthcare.in . The company has established this dedicated communication channel to address investor queries and provide necessary support for call participation.

Historical Stock Returns for Aster DM Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+0.42%-6.97%-6.65%-6.83%+11.61%+260.56%

Aster DM Healthcare Schedules Board Meeting for January 30, 2026 to Review Q3FY26 Results and ESOS 2026 Adoption

2 min read     Updated on 23 Jan 2026, 05:43 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Aster DM Healthcare Limited has scheduled a board meeting for January 30, 2026, to review Q3FY26 financial results for the quarter and nine months ended December 31, 2025, and consider adopting the Employee Stock Option Scheme 2026. The meeting, announced on January 23, 2026, complies with SEBI Regulation 29 requirements, with the ESOS 2026 subject to shareholder approval under applicable securities regulations.

30716000

*this image is generated using AI for illustrative purposes only.

Aster DM Healthcare Limited has announced that its Board of Directors will convene on January 30, 2026, to deliberate on key corporate matters including quarterly financial results and a new employee stock option scheme. The meeting notification was issued on January 23, 2026, in compliance with regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The board meeting has been scheduled to address two primary agenda items that will shape the company's financial disclosure and employee compensation framework.

Agenda Item: Details
Financial Results Review: Unaudited Standalone and Consolidated financial results for Q3FY26
Reporting Period: Quarter and nine months ended December 31, 2025
ESOS 2026 Adoption: New Employee Stock Option Scheme under SEBI regulations
Regulatory Compliance: Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

Financial Results Consideration

The board will review and approve the company's unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. This quarterly review represents the third quarter of the fiscal year 2026, providing stakeholders with insights into the company's operational and financial performance during this period.

Employee Stock Option Scheme 2026

A significant agenda item involves the proposed adoption of the Aster DM Healthcare Limited Employee Stock Option Scheme 2026 (ESOS 2026). The scheme is designed to align with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and other applicable legal frameworks.

ESOS 2026 Parameters: Details
Scheme Name: Aster DM Healthcare Limited Employee Stock Option Scheme - 2026
Regulatory Framework: SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
Approval Requirement: Subject to shareholder approval
Implementation Status: Pending board and shareholder consent

Regulatory Compliance

The meeting notification was issued under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency and timely communication with stock exchanges and stakeholders. The company has informed both BSE Limited and The National Stock Exchange of India Limited about the scheduled board meeting.

The ESOS 2026 adoption, if approved by the board, will be subject to subsequent shareholder approval, maintaining corporate governance standards and regulatory compliance. The scheme aims to provide employee benefits while adhering to current securities regulations governing share-based compensation structures.

Historical Stock Returns for Aster DM Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+0.42%-6.97%-6.65%-6.83%+11.61%+260.56%

More News on Aster DM Healthcare

1 Year Returns:+11.61%